Pregmune offers the IRMA™ assessment, which utilizes machine learning algorithms and clinical data to identify immunological factors contributing to infertility, miscarriages, and IVF failures. This platform provides personalized treatment recommendations based on the assessment results, enhancing the chances of successful pregnancies.
Funding
$700K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Couples experiencing infertility, recurrent miscarriages, or repeated IVF failures often lack a comprehensive understanding of underlying immunological factors that may be contributing to these issues. Standard fertility evaluations may overlook subtle immune imbalances, leading to ineffective treatments and prolonged time to pregnancy.
Solution
Pregmune offers the IRMA™ (Immunological Reproductive Medicine Assessment), a machine-learning-driven platform that analyzes a patient's clinical and laboratory data to identify specific immunological factors associated with reproductive challenges. The assessment evaluates parental compatibility (HLA mismatches), natural killer cell activity, systemic inflammation, thrombophilia, and autoimmunity. Based on the IRMA™ results, Pregmune provides personalized treatment recommendations to the patient's physician, with the goal of addressing identified immune imbalances and improving the chances of a successful pregnancy. The IRMA™ report assists physicians in diagnosing and treating reproductive issues by determining appropriate immunological follow-up care.
Target Audience
The primary audience includes individuals and couples experiencing infertility, recurrent miscarriages, or IVF failures, as well as reproductive endocrinologists, OB/GYNs, and other healthcare providers involved in fertility treatment.
Features
- Machine learning algorithms analyze clinical data and lab results to identify immunological factors contributing to reproductive failure.
- Assessment covers a range of immunological factors, including HLA mismatches, NK cell activity, inflammation, thrombophilia, and autoimmunity.
- Personalized treatment recommendations are generated based on the IRMA™ results.
- Comprehensive report is provided to the patient's physician, including guidance for follow-up treatment.
- Online patient portal provides access to the IRMA™ report as a downloadable PDF file.
- Every lab test result is reviewed, validated, and interpreted by Pregmune's medical and research team.